anaemia
These data suggest that the correction of chemotherapy-induced anaemia by rhEPO (epoetin beta) treatment increases tumour radiosensitivity, presumably as a result of an improved oxygen supply to tumour tissue.
These data suggest that the correction of chemotherapy-induced <span class="disease" id="9743294-8-63-70">anaemia</span> by rhEPO (<span class="gene" id="9743294-8-81-88">epoetin</span> beta) treatment increases tumour radiosensitivity, presumably as a result of an improved oxygen supply to tumour tissue.